• 1
    Taylor CP, Gee NS, Su TZ. et al A summary of mechanistic hypothesis of gabapentin pharmacology. Epilepsy Res 1998; 29: 23349.
  • 2
    Stefani A, Spadoni F, Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 1998; 37: 8391.
  • 3
    Bartoszyk GD, Fritschie, Herrmann M. et al Indications for an involvement of the GABA-system in the mechanism of action of gabapentin [Abstract]. Arch Pharmacol 1983; 322(suppl):R94.
  • 4
    McDonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1993;34(suppl 5):S18.
  • 5
    Taylor CP. Mechanisms of action of gabapentin. Drugs Today 1998; 34(suppl D):311.
  • 6
    Crawford P, Ghadiali E, Lang R. et al Gabapentin as an antiepileptic drug in man. J Neurol Neurosurg Psychiatry 1987; 50: 6826.
  • 7
    Bower G, Bochinger D, Castell M. et al Gabapentin in the treatment of drug resistant epileptic patients. Adv Epileptol 1989; 7: 21921.
  • 8
    Sivenius J, Kalviainen R, Ylinen A. et al Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia 1991; 32: 53942.
  • 9
    UK Gabapentin Study Group. Gabapentin and partial epilepsy. Lancet 1990; 335:11147.
  • 10
    US Gabapentin Study Group No. 5 Gabapentin as add on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993; 43:22928.
  • 11
    Anhut H, Ashman P, Feuerstein TJ. et al Gabapentin (Neurontin) as add on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 1994; 35: 795801.
  • 12
    Beydoun A, Fischer J, Labard R. et al Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from poly-therapy in outpatients with refractory complex partial or secondary generalized seizures. Neurology 1997; 49: 74652.
  • 13
    Bergey GK, Morris HH, Rosenfeld W. et al Gabapentin mono-therapy: 1. An eight day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. Neurology 1997; 49: 73945.
  • 14
    Leber PD. Hazards of inference: the active control investigation. Epilepsia 1989;30(suppl 1):S5763.
  • 15
    Trudeau V, Myers S, LaMoreaux L, Anhut H, Garfalo E, Ebersole J. Gabapentin in naïve childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 1996; 11: 4705.
  • 16
    Chadwick DW, Liederman DB, Sauermann W, Alexander J, Garfalo E. Gabapentin in generalized seizures. Epilepsy Res 1996; 25: 1917.
  • 17
    Appleton R, Fichtner K, Murray G. et al Gabapentin in children with refractory partial seizures: a 12-week, double-blind, placebo-controlled study [Abstract]. Proc Am Epilepsy Soc Meet 1998;.
  • 18
    Bourgeois B, Brown LW, Pellock JM. et al Gabapentin mono-therapy in children with benign childhood epilepsy with centro-temporal spikes (BECTS): a 36-week, double-blind, placebo-controlled study [Abstract]. Am Proc Epilepsy Soc Meet 1998;.
  • 19
    Chadwick DW, Anhul H, Griener MJ. et al A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group. Neurology 1998; 51: 12828.
  • 20
    Morreli M. et al Efficacy of gabapentin as adjunctive therapy in a large multicenter study. [submitted].
  • 21
    Bruni J. Outcome observation of gabapentin as add-on therapy for partial seizures. “NEON” Study Investigators Group. NEON evaluation of outcomes in neurological practice. Can J Neurol Sci 1998; 25: 13440.
  • 22
    Beydoun. A, Fakhouri T, Nasreddine W, Abou-Khalil B. Conversion to high dose gabapentin monotherapy in patients with medically refractory epilepsy. Epilepsia 1998; 39: 18893.
  • 23
    Wilson AE, Sills GJ, Forrest G, Brodie MJ. High dose gabapentin in refractory partial seizures: clinical observations in 50 patients. Epilepsy Res 1998; 29: 1616.
  • 24
    Khaurana DS, Riviello J, Helmers S, Holmes G, Anderson J, Mikati MA. Efficacy of gabapentin therapy in children with refractory partial seizures. J Pediatr 1996; 128: 82933.
  • 25
    Lee DO, Steingard RJ, Cesna M. et al Behavioral side effects of gabapentin in children. Epilepsia 1996; 37: 8790.
  • 26
    Tallian KB, Nahata MC, Low W. et al Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia 1996; 37: 5012.
  • 27
    Wolf SM, Shinnar S, Kang H. et al Gabapentin toxicity in children manifesting as behavior changes. Epilepsia 1996; 36: 12035.
  • 28
    Morris GL. Efficacy and tolerability of gabapentin in clinical practice. Clin Ther 1995; 17: 891900.
  • 29
    Harden CL, Hosain S, Nikolov B, Labar DR. Evaluation of gabapentin in an outpatient and office-based sample of epilepsy patients. J Epilepsy 1998; 11: 1305.
  • 30
    Baulac M, Cavalcanti D, Semah F, Arzimanoglou A, Poltal JJ. Gabapentin add-on therapy with adaptable doses in 610 patients with partial epilepsy: an open observational study. The French Gabapentin Collaborative Group. Seizure 1998; 7: 5562.
  • 31
    Browne TR. Efficacy and Safety of Gabapentin. In: ChadwickD. ed. New trends in epilepsy management: the role of gabapentin. London : Royal Society of Medicine Services, 1993: 4757.
  • 32
    US Gabapentin Study Group. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug resistant partial epilepsy. Epilepsy Res 1994; 18: 6773.
  • 33
    Walker MC, Patsalos PN. The tolerability and safety profile of gabapentin. Rev Contemp Pharmacother 1996; 7: 24957.
  • 34
    Parke-Davis. Data on file. Morris Plains, NJ, 1993.
  • 35
    Ramsey RE. Clinical efficacy and safety of gabapentin. Neurology 1994;44(suppl 5):S2330.
  • 36
    NeurontinR. Gabapentin capsules package insert. Morris Plains, NJ, 1993.
  • 37
    Fischer RS, Penovich P, Pellock J, Sachdeo R. A multicenter, randomized, double-blind comparative study of gabapentin administered as an initial dosage of 900 mg/day versus a dosage titrated to 900 mg/d over 3 days. Neurology 1996; 46(suppl):A169.
  • 38
    Gidal BE, Maly MM, Budde J, Lensmeyer GL, Pitterle ME, Jones JC. Effect of a high-protein meal on gabapentin pharmacokinetics. Epilepsy Res 1996; 23: 716.